Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
... rates in women undergoing controlled ovarian stimulation
(COS) with a standardized rFSH / ... rFSH, followed by rFSH (maximum 200 IU/day) from stimulation
day eight onward, when required. Starting on stimulation
day five, all patients received 0.25 mg ...
Under the Microscope: 'Micro IVF'
... IVF,' also referred to as 'Mini IVF' or 'Minimal stimulation
IVF' at FertilityTies.com
LOS ANGELES, April ... "Micro IVF," also called "Mini IVF" or "Minimal stimulation
IVF." FertilityTies is the only comprehensive ... to about 50% today. We have become better with stimulation
protocols and techniques over this time period. ...
Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients
every-other-day dosing of ANA773, immune stimulation
of a magnitude
believed to confer therapeutic ... without adverse
toxicology findings. The immune stimulation
observed with every-other-day
dosing of ANA773 in ... (iv) the belief that ANA773 can elicit immune stimulation
magnitude sufficient to confer therapeutic ...
UK's NICE Recommends Spinal Cord Stimulation for Patients with Chronic Neuropathic Pain
... (NICE) recommending
the use of spinal cord stimulation
(SCS) for patients with chronic
neuropathic pain. ... to
select the appropriate SCS system, patients' stimulation
anticipated longevity of device ... and Clinical Excellence (NICE). Spinal Cord stimulation
for chronic pain of neuropathic and ischemic ...
Scientists restore movement to paralyzed limbs through artificial brain-muscle connections
... the activity in the monkey's brain to electrical stimulation
delivered to the paralyzed wrist muscles. The ... Other researchers have delivered artificial stimulation
directly to paralyzed arm muscles in order to ... movementa technique called functional electrical stimulation
(FES). The Fetz study is the first to combine a ...
Victhom announces the filing of a patent application to address sudden unexplained death in epilepsy (SUDEP)
... that aim at treating seizures, include neuromodulation devices for stimulation
of the vagus nerve by Cyberonics and a deep brain stimulation
product, Medtronic's Intercept(TM) Epilepsy Control System, which is ...
Cyberonics Provides Update on Business Operations Following Hurricane Ike
... The Company
expects to resume emergency shipments of its Vagus Nerve stimulation
Therapy(TM) System this Wednesday, September 17th, and anticipates ... in neuromodulation. The company developed and markets the
Vagus Nerve stimulation
(VNS) Therapy(TM) System, which is FDA-approved for
the treatments of ...
Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights
... studies have shown that with
every-other-day dosing of ANA773, immune stimulation
of a magnitude
believed to confer therapeutic potential can be achieved ... a pharmacologically active dose and
establish the profile of immune stimulation
by year-end, which will support
the design of future clinical trials of ...
Kingfisher Healthcare Launches Breakthrough Product in Europe
... medical device for home use. The KFH Energy utilizes Bio-Electric stimulation
Therapy (BEST) to
deliver extremely low currents to the body. BEST works ... products. It utilizes a technology platform called BEST
Therapy), from which unique products are
developed. These products ...
GeoVax Labs, Inc. Provides Clinical Studies Update
... DNA and a recombinant modified vaccinia Ankara (MVA), is designed to stimulate both anti-HIV T cell and anti-HIV antibody immune responses. stimulation
of both T cells and antibodies differentiates the GeoVax vaccine from many other vaccine candidates. GeoVax's DNA and MVA vaccines are used in a ...
Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
... the recruitment and proliferation of cells such as monocytes, fibroblasts and endothelial cells. These cell types are critical for the effective stimulation
of a variety of wound healing processes.
The Excellarate product candidate is designed to require only one or two physician-administered ...
First ASMS Hites Award for Outstanding Research Publication Presented to Prof. Alison Ashcroft for Her Use of Waters Synapt HDMS System to Explore Protein Complexes
... Molecular Biology at the University of Leeds.
ASMS judged the publication on the basis of its "innovative aspects, technical quality, likely stimulation
of future research, likely impact on future applications, and the quality of the presentation."
Prof. Ashcroft received the Award and $2,000 ...
Scientists moving closer to 'artificial noses'
... when exposed to an oscillating inhomogeneous electric field, and their vibration then measured.
The alternating electric field required for this stimulation
was produced between two gold electrodes right up close to the string. The oscillations were measured by two other electrodes. "We created this setup ...
FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)
... receiving SYMBICORT should not use additional formoterol or other long-acting inhaled beta2-agonists for any reason.
Excessive beta-adrenergic stimulation
has been associated with central nervous system and cardiovascular effects. SYMBICORT, like all products containing sympathomimetic amines, should be ...
INVO Bioscience Completes Reverse Merger
... on February 17, 2009 at www.sec.gov .
About the INVOcell Procedure
The INVOcell and INVO Procedure combine a natural or mild stimulation
infertility treatment cycle, using lower amounts of injectable fertility hormones than used in traditional IVF(in vitro fertilization), with ...
Uroplasty Reports Third Quarter Fiscal 2009 Results
... Our focus is the
continued commercialization of our Urgent PC system, which we believe is the
only FDA-approved minimally invasive nerve stimulation
device designed for
office-based treatment of urinary urgency, urinary frequency and urge
incontinence -- symptoms often associated with overactive ...
Victhom to Participate in the OneMedPlace Finance Forum
... paralysis of the leg as a result of hemiparetic stroke.
The Neurostep(R) System has been engineered to integrate with the body's
natural sensing and stimulation
network and designed to closely mimic specific
functions that have been interrupted or lost due to disease or injury. The
Neurostep(R) is an ...
Cyberonics Provides Business Update on Depression Clinical Trial
... Inc. (NASDAQ: CYBX ) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve stimulation
(VNS) Therapy(TM) System, which is FDA-approved for the treatments of refractory epilepsy and treatment-resistant depression. The VNS Therapy System ...
New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinson's Disease Drug Development
pain, dementia, psychosis, neuroprotection, impulse control (punding),
restless legs syndrome;
-- Deep brain stimulation
-- Gene therapies and growth factors (human fetal implants, GDNF,
neurturin, neublastin, GAD/glutamic ...
Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist
... CID remains therefore a huge unmet medical need. ZP1846 has a
tremendous therapeutic potential by virtue of its unique mechanism of gut
and reduction of gut atrophy and weight loss induced by
the mucosal toxicity of chemotherapy. This project gives us the extraordinary
opportunity to ...
Metabolex Announces Positive Results From Phase 1a Clinical Trial of MBX-2982
... preserve beta cell health. This novel dual mechanism
may provide a unique therapeutic benefit in the treatment of type 2
diabetes. Additionally, the stimulation
of GLP-1 release may mimic the
benefits of incretin analogues such as exenatide (a GLP-1 analogue marketed
as Byetta(R)). Unlike exenatide, however, ...
Two Metabolex Projects Recognized in Windhover's Top 10 Lists for Partnering Opportunities
... preserve beta cell health. This novel
dual mechanism may provide a unique therapeutic benefit in the treatment of
type 2 diabetes. Additionally, the stimulation
of GLP-1 release may mimic
the benefits of incretin analogues such as exenatide (a GLP-1 analogue
marketed as Byetta(R)). Unlike exenatide, however, ...
Presenters Announced For MichBio Expo's Emerging Business Showcase
... - Non-invasive surgical modality using ultrasound energy to liquefy target tissue. Jade Biomed. - Needle-free acupuncture point evaluation and stimulation
system. NamesforLife, LLC. - Innovative products to extract meaning from information based on rapidly changing, dynamic terminologies. ...
Ferring Celebrates Winner of 2008 My Little Miracle Essay Contest During National Infertility Awareness Week
... ovary syndrome. Like all
gonadotropins, these are potent substances capable of causing mild to
severe adverse reactions, including Ovarian Hyper stimulation
(OHSS), with or without pulmonary or vascular complications, in women
undergoing therapy for infertility. Only physicians thoroughly ...
US College Students Needing TB Testing Now Have the Benefit of QFT(TM)
... on measurement of a cell-mediated immune
response in TB- infected individuals. The T-cells of these individuals are
sensitized to TB, and respond to stimulation
with peptides simulating those
expressed by the TB causing bacteria, secreting a cytokine called
interferon-gamma. QFT accurately measures the ...
Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) 2008 Winners Announced
... an enormous boost for our research. We feel
looking at gene expression in cumulus cells will help understand the
mechanism behind different ovarian stimulation
protocols and how they
influence oocyte quality. It is an honour for the value of our research to
be recognised." Dr Esther Baart.
NovaVision Appoints Medical Technology Veteran Rudy Mazzocchi as Chief Executive Officer
... perform daily for six-to-seven months.
Patients gradually improve their vision through the repeated detection of a
specific pattern of optical stimulation
directed at the border between the
seeing and blind areas of the visual field.
About NovaVision, Inc.
NovaVision, Inc., headquartered in Boca ...
Cyberonics Reports Strong Revenue Growth and Profitability in Fiscal 2008 Fourth Quarter
... Inc. (Nasdaq: CYBX ) is a medical technology company with
core expertise in neuromodulation. The company developed and markets the
Vagus Nerve stimulation
(VNS) Therapy(TM) System, which is FDA-approved for
the treatments of epilepsy and treatment-resistant depression. The VNS
Therapy System uses a ...
Two Year Study Confirms SUPPRELIN(R) LA Implant Maintains Profound Suppression of Hormones in Children With Premature Onset Puberty
... annually. Primary outcome
was peak luteinizing hormone (LH), which helps regulate the menstrual cycle
and egg production in females, after GnRHa stimulation
Peak LH declined from 0.92 +/- 0.58 mIU/mL at 12 months to 0.51 +/-
0.33 mIU/mL at 24 months (p< 0.0001) in the naive group and from 0.74 ...
Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights
... profile of ANA773 in the ongoing Phase I trial and expects to identify pharmacologically active doses and establish the profile of immune stimulation
this year, which information will support the future design of clinical trials of ANA773 (alone or in combinations) in specific tumor types. ...
Biofisica Obtains $2.3 Million in Financing From Investors
... founder of Biofisica.
POSiFECT is the first medical device available that combines two
technologies - moist wound-care dressing and electrical stimulation
- in a
fully disposable, easy-to-use, sterile dressing that facilitates the normal
healing process. Clinical research has shown that POSiFECT ...
Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system
... products in the
neuromodulation industry that can deliver therapy to patients in a more
effective manner than the continuous or pre-programmed stimulation
delivered by current generation devices". Mr. Kameli also stated: "With
these promising initial results on the CLS platform proof of concept ...
Boston Scientific Announces Japanese Approval of Heart Failure Lead
... the left side of the heart, which Boston
Scientific refers to as Electronic Repositioning(TM). This ability allows
physicians to change the stimulation
site non-invasively after implant,
which helps avoid the need for an additional surgical procedure. Boston
Scientific is the only company that ...
PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
... neurophysiological and neuroimaging
measures used in cognitive function research. His research background also
includes genetics, antidepressive stimulation
techniques, and sleep
medicine. Dr. Bajbouj is a Professor at the Charite University in Berlin,
Germany, where he heads the Electroencephalography ...
Kingfisher Healthcare Receives European CE Mark for Next Generation Wound Healing Device
... to use safe, non-invasive energy to treat
patients suffering from chronic conditions. It utilizes a technology
platform called BEST (Bio-Electric stimulation
Therapy) from which unique
products are developed by Kingfisher Healthcare. Headquartered in
Albuquerque, New Mexico, Kingfisher Americas focuses on ...
Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
... endopeptidase. In animal models, PL-3994 was able to induce
diuresis with a limited decrease in blood pressure, with these effects
mediated through stimulation
of production of cGMP. PL-3994 is well
absorbed by the subcutaneous route of administration.
About Congestive Heart Failure (CHF)
Currently in ...
Angiotech and Symphony Medical Announce Licensing Agreement
... grafting (CABG) and cardiac valve surgeries. The
product under development is a kit which employs a biopolymer, applicator
and specialized electrical stimulation
device. The concept is protected by
a number of patents which are currently pending.
"We are excited about the opportunity to work with ...
GlaxoSmithKline Announces Data on TYKERB(R) (Lapatinib) Plus Capecitabine for the Treatment of HER2 Positive Breast Cancer Brain Metastases
... About TYKERB/TYVERB(3)
TYKERB/TYVERB (lapatinib) is a first-in-class oral small-molecule
inhibitor of the HER2 (ErbB2) tyrosine kinase receptor. stimulation
is associated with cell proliferation and with multiple processes involved
in tumor progression and metastases. Overexpression of this ...
JCI table of contents: Dec. 3, 2007
... mice deficient in STAT1 lacked the chromosomal duplication inherent to this cell type. The authors concluded from these results that inflammatory stimulation
of STAT1 can lead to thrombocytosis through enhanced differentiation of platelet precursor cells.
TITLE: STAT1 promotes megakaryopoiesis ...
Swiss Experts Recommend QuantiFERON(R)-TB Gold for Tuberculosis Infection Screening Prior to Initiating anti-TNF-a Therapy
... on measurement of a cell mediated
immune response in TB-infected individuals. The T cells of these
individuals are sensitized to TB, and respond to stimulation
simulating those expressed by the TB causing bacteria, secreting a cytokine
called interferon- a. QFT(TM) accurately measures the ...